Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
Public ClinicalTrials.gov record NCT02087943. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate to Severe Atopic Dermatitis
Study identification
- NCT ID
- NCT02087943
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Amgen
- Industry
- Enrollment
- 191 participants
Conditions and interventions
Conditions
Interventions
- Apremilast Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2014
- Primary completion
- Sep 30, 2015
- Completion
- Jan 31, 2016
- Last update posted
- May 6, 2020
2014 – 2016
United States locations
- U.S. sites
- 15
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Research Center | Phoenix | Arizona | 85023 | — |
| Bakersfield Dermatology and Skin Cancer Medical Group | Bakersfield | California | 93309 | — |
| Dermatology Research Associates | Los Angeles | California | 90045 | — |
| Renstar Medical Research | Ocala | Florida | 34471 | — |
| Emory Clinic | Atlanta | Georgia | 30322 | — |
| Advanced Medical Research | Atlanta | Georgia | 30342 | — |
| Northwestern University Northwestern Medical Faculty Foundation | Chicago | Illinois | 60611 | — |
| Northwestern Medicine Lake Forest Hospital | Lake Forest | Illinois | 60045 | — |
| Dermatology Specialists, PSC | Louisville | Kentucky | 40202 | — |
| Dartmouth Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | — |
| NYU Department of Dermatology | New York | New York | 10016 | — |
| Mount Sinai Medical Center | New York | New York | 10029 | — |
| PMG Research of Winston-Salem LLC | Winston-Salem | North Carolina | 27103-3914 | — |
| Oregon Health and Science University | Portland | Oregon | 97201-3098 | — |
| Virginia Clinical Research Inc | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02087943, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 6, 2020 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02087943 live on ClinicalTrials.gov.